Trial Profile
A prospective study evaluated the safety and efficacy of sofosbuvir in combination with simeprevir +/- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Mar 2016
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 11 Mar 2016 New trial record